To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Clinical trial NCT06833983 · RECRUITING
Trial details
- NCT number
- NCT06833983
- Sponsor
- Gritgen Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2026-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.